vcvibes

Breakout Management, LLC

SEC exempt reporting adviser (venture capital exemption).

HQ
CA

Breakout Management, LLC backs founders building science-driven companies, typically investing early when founding teams are coalescing. Lindy Fishburne and Julia Moore are managing partners, with Dana Watt and Rebecca Nugent as partners. Portfolio companies span AI-driven cancer therapies, carbon-to-chemicals technology, and sepsis diagnostics.

01 · Says / Does

TagSaysDoesHistorically (to 2020)
StagesNot statedNot enough dated dealsSeries B, Series A
SectorsNot statedNot enough dated dealsBiotech, Healthtech, Data analytics, Life sciences and research tools
RegionsNot statedNot enough dated dealsCA

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

Historical focus (through 2020), derived from historical deal data.

YearDealsTop sectors
20163Biotech, Advanced materials, Agtech
20172Biotech, Data analytics, Healthtech
20181Biotech, Healthtech
20195Biotech, Data analytics, Life sciences and research tools
20201Healthtech, Medical devices

Stage mix over time

2016 Series A: 12016 Series B: 2162017 Series B: 1172018 Series B: 1182019 Seed: 12019 Series A: 22019 Series B: 2192020 Series A: 120212223242526
  • Pre-seed
  • Seed
  • Series A
  • Series B
  • Growth
Share of rounds by stage, per year. Striped years have fewer than 3 rounds.Historical focus (through 2020), derived from historical deal data.
Rounds by stage and year
YearPre-seedSeedSeries ASeries BGrowth
201600120
201700010
201800010
201901220
202000100
202100000
202200000
202300000
202400000
202500000
202600000

02 · Fund history

FundYearSizeStatus
Breakout Ventures III-B, L.P.

Breakout backs founders building science-driven companies, investing early when founding teams are coalescing. It leads many deals and sees science becoming programmable, with AI applied to biological and chemical data. Inferred from the firm's website

2025$12.12M (Form D)Open, writing first checks
Breakout Ventures III, L.P. /DE

Breakout backs founders building science-driven companies, investing early when founding teams are coalescing. It leads many deals and sees science becoming programmable, with AI applied to biological and chemical data. Inferred from the firm's website

2024$101.88M (Form D)Open, writing first checks
Breakout Ventures II, L.P.2021$112.5M (Form D)Follow-ons only

03 · People across funds

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

  1. HTTP://BREAKOUT.VC/
  2. https://breakout.vc/contact
  3. https://breakout.vc/about
  4. https://breakout.vc/portfolio
  5. https://breakout.vc/

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026